Onconetix Corp (ONCO): רווח נקי למניה (EPS TTM)

Onconetix, Inc. (ONCO) focuses on men's health, minimizing environmental impact through digitalization and sustainable resource management. The 12-month EPS trend reflects current dynamics, where this metric equals -1971.30. Patents in radiosensitization and strict FDA oversight serve as a defensive moat for the business. However, a high burn rate and the consequences of a profile shift create financial risks regarding the company's viability.
פילוחי מדדים פיננסיים ומדדי שוק עבור Onconetix Corp (ONCO)

Earnings per share (EPS TTM) measures the portion of profit allocated to each outstanding share of common stock over a trailing twelve-month period. This metric allows investors to objectively compare the efficiency of different issuers by neutralizing differences in capital. Analyzing this 12-month net income per share chart enables an assessment of the business's scaling pace. For Onconetix, Inc. (ONCO), this indicator reflects financial stability amid stringent FDA oversight. Patents for radiosensitization establish the foundation for future profit growth.